Immediate Impact
6 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
2023 Standout
Works of Fernando Ramos Lopez being referenced
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
2022
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fernando Ramos Lopez | 18 | 26 | 15 | 18 | 6 | 53 | |
| Rebecca Makinson | 18 | 16 | 15 | 15 | 8 | 52 | |
| Jacqueline D. Chu | 18 | 18 | 24 | 23 | 8 | 65 | |
| Carina C. D. Joe | 22 | 20 | 17 | 22 | 7 | 54 | |
| Ahmad Hosseinzadeh Adli | 17 | 38 | 13 | 16 | 7 | 73 | |
| Adam DeZure | 37 | 25 | 9 | 12 | 5 | 70 | |
| Danielle Morelle | 28 | 40 | 48 | 15 | 6 | 96 | |
| Gurpreet Brar | 32 | 53 | 36 | 26 | 5 | 98 | |
| I. Abrrey Monreal | 23 | 32 | 8 | 23 | 9 | 62 | |
| Stephanie Ostrowski | 34 | 21 | 8 | 16 | 8 | 82 | |
| Rameswara R. Segireddy | 15 | 15 | 8 | 9 | 6 | 41 |
All Works
Login with ORCID to disown or claim papers
Loading papers...